KALA BIO Stock (NASDAQ:KALA)
Previous Close
$1.64
52W Range
$1.10 - $20.60
50D Avg
$10.45
200D Avg
$6.96
Market Cap
$11.02M
Avg Vol (3M)
$981.25K
Beta
-2.11
Div Yield
-
KALA Company Profile
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.